Delivery Order SPE2DB22D3009-SPE2DB25FAP83

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,695.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the provision of RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.83 Firm Fixed Price Delivery Order is for the supply of 4561454598 - RAMELTEON 8 MG TABLET 30S. The contract has an ultimate completion date of July 11, 2023 and was awarded on July 10, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, identified as SPE2DX15D1022|SPE2DX25FVCUM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $12,401.70, is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. This appears to be a Firm Fixed Price delivery order contract, with a performance period extending to March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, valued at $1,628.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a generic pharmaceutical product, with a period of performance through May 14, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award, with the identification number SPE2DB22D1202|SPE2DB24FUKR3, is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,389.38, is for the delivery of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price agreement, with an ultimate completion date of December 19, 2023. Amerisourcebergen Drug Corp,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a medication used for the treatment of insomnia. The contract has a ceiling value of $6,418.61 and a period of performance through February 24, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,496.95 firm-fixed-price delivery order is for the supply of 4565439755 RAMELTEON 8 MG TABLET UD 50S, a prescription medication. The award has an ultimate completion date of August 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,432.06 firm-fixed-price delivery order provides 4566170446 ramelteon 8 mg tablets to support military healthcare programs. The award has an ultimate completion date of October 22, 2024 and was issued on October 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.56 firm fixed-price delivery order covers the supply of Ramelteon 8 mg tablets for the DLA Troop Support Medical program. The contract has a period of performance through November 27, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAP83
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3009 | SPE2DB25FAP83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,508.08, is a Delivery Order for the supply of 4,567,074,312 units of the medication RAMELTEON 8 MG TABLET 100S. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This appears to be a standard open competition contract, as it does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:54 AM